X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-04-22 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $148.92 | -2,161 | 75,557 | -3% | -$321,809 | |||||
2025-04-21 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $21.52 | -5,644 | 353,631 | -2% | -$121,448 | ||||||
| D | 2025-04-21 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $145.55 | -610 | 76,468 | -1% | -$88,784 | |||||
| D | 2025-04-21 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $145.55 | -1,664 | 198,365 | -1% | -$242,190 | |||||
2025-04-21 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $145.55 | -343 | 156,946 | 0% | -$49,922 | ||||||
2025-04-21 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $145.56 | -296 | 141,486 | 0% | -$43,085 | ||||||
| D | 2025-04-21 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $145.55 | -470 | 225,667 | 0% | -$68,408 | |||||
| D | 2025-04-21 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale+OE | $145.55 | -86 | 335,917 | 0% | -$12,517 | |||||
2025-04-17 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale | $44.79 | -116 | 3,345 | -3% | -$5,196 | ||||||
| M | 2025-04-08 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.19 | -5,644 | 359,275 | -2% | -$113,932 | |||||
2025-04-07 | CDNA | Caredx, Inc. | Jain Abhishek | CFO | S - Sale | $17.72 | -265 | 337,418 | 0% | -$4,696 | ||||||
2025-04-07 | CDNA | Caredx, Inc. | Novack Jeffrey Adam | Secretary, GC | S - Sale | $17.72 | -924 | 126,911 | -1% | -$16,373 | ||||||
2025-04-07 | SERA | Sera Prognostics, Inc. | Mirza Mansoor Raza | Dir | S - Sale | $3.35 | -107 | 43,778 | 0% | -$358 | ||||||
| M | 2025-04-04 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $136.13 | -6,070 | 335,813 | -2% | -$826,327 | |||||
2025-04-02 | DGX | Quest Diagnostics Inc | Davis J. E. | CEO, Pres | S - Sale | $168.46 | -39,191 | 127,623 | -23% | -$6,602,074 | ||||||
2025-04-02 | DGX | Quest Diagnostics Inc | Kuppusamy Karthik | SVP, Clinical Solutions | S - Sale | $170.00 | -2,555 | 12,546 | -17% | -$434,350 | ||||||
| D | 2025-04-01 | NTRA | Natera, Inc. | Marcus Gail Boxer | Dir | S - Sale+OE | $140.78 | -4,000 | 9,704 | -29% | -$563,100 | |||||
2025-04-01 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $140.48 | -3,000 | 141,782 | -2% | -$421,428 | ||||||
| A | 2025-03-11 | GRAL | Grail, Inc. | Freidin Aaron | CFO | S - Sale | $31.20 | -1,816 | 335,170 | -1% | -$56,659 | |||||
| A | 2025-03-11 | GRAL | Grail, Inc. | Ragusa Robert P | CEO | S - Sale | $31.21 | -7,625 | 828,662 | -1% | -$237,976 | |||||
| A | 2025-03-11 | GRAL | Grail, Inc. | Ofman Joshua J. | Pres | S - Sale | $31.20 | -2,109 | 559,673 | 0% | -$65,801 | |||||
| D | 2025-03-31 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $138.41 | -2,562 | 75,557 | -3% | -$354,603 | |||||
| DM | 2025-03-31 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $139.70 | -25,461 | 196,643 | -11% | -$3,556,948 | |||||
| D | 2025-03-31 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $138.41 | -1,404 | 225,281 | -1% | -$194,327 | |||||
2025-03-28 | LH | Labcorp Holdings Inc. | Summy Amy B. | EVP, CMO | S - Sale | $231.67 | -758 | 5,302 | -13% | -$175,606 | ||||||
2025-03-28 | LH | Labcorp Holdings Inc. | Schroeder Mark S | EVP, Pres Diagnostics, COO | S - Sale | $231.67 | -2,635 | 4,960 | -35% | -$610,450 | ||||||
2025-03-26 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.30 | -5,644 | 364,919 | -2% | -$114,573 | ||||||
2025-03-25 | XGN | Exagen Inc. | Nmsic Co-Investment Fund, L.P. | 10% | S - Sale | $3.30 | -350,000 | 1,758,958 | -17% | -$1,155,000 | ||||||
2025-03-19 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale | $43.70 | -116 | 3,211 | -3% | -$5,069 | ||||||
2025-03-17 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $146.03 | -6,702 | 203,354 | -3% | -$978,678 | ||||||
2025-03-17 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $146.04 | -792 | 71,869 | -1% | -$115,661 | ||||||
| M | 2025-03-17 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $145.62 | -5,881 | 341,883 | -2% | -$856,410 | |||||
2025-03-17 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $146.04 | -1,127 | 2,448,288 | 0% | -$164,584 | ||||||
2025-03-17 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale | $146.04 | -928 | 224,185 | 0% | -$135,521 | ||||||
2025-03-17 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $146.04 | -1,026 | 144,782 | -1% | -$149,836 | ||||||
2025-03-17 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $146.04 | -795 | 157,289 | -1% | -$116,099 | ||||||
2025-03-17 | DGX | Quest Diagnostics Inc | Prevoznik Michael E | SVP, GC | S - Sale | $170.00 | -4,643 | 43,758 | -10% | -$789,310 | ||||||
| M | 2025-03-17 | RDNT | Radnet, Inc. | Hames Norman R | Pres, COO-West Operations | S - Sale | $49.42 | -15,000 | 251,959 | -6% | -$741,300 | |||||
| D | 2025-03-17 | GH | Guardant Health, Inc. | Kalia Kumud | CIO | S - Sale+OE | $43.16 | -3,500 | 19,720 | -15% | -$151,060 | |||||
| D | 2025-03-14 | FTRE | Fortrea Holdings Inc. | Hanson James S. | GC | S - Sale+OE | $9.70 | -1,007 | 9,466 | -10% | -$9,768 | |||||
| D | 2025-03-14 | FTRE | Fortrea Holdings Inc. | Morais Mark A. | COO | S - Sale+OE | $9.70 | -1,207 | 38,672 | -3% | -$11,708 | |||||
| D | 2025-03-14 | FTRE | Fortrea Holdings Inc. | McConnell Jill G. | CFO | S - Sale+OE | $9.70 | -1,210 | 40,467 | -3% | -$11,737 | |||||
2025-03-14 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $147.71 | -50,000 | 2,449,415 | -2% | -$7,385,249 | ||||||
| D | 2025-03-12 | NTRA | Natera, Inc. | Marcus Gail Boxer | Dir | S - Sale+OE | $147.69 | -4,000 | 9,704 | -29% | -$590,773 | |||||
| D | 2025-03-13 | FTRE | Fortrea Holdings Inc. | Morais Mark A. | COO | S - Sale+OE | $9.93 | -203 | 35,596 | -1% | -$2,016 | |||||
| D | 2025-03-13 | FTRE | Fortrea Holdings Inc. | McConnell Jill G. | CFO | S - Sale+OE | $9.93 | -261 | 37,394 | -1% | -$2,592 | |||||
| D | 2025-03-12 | FTRE | Fortrea Holdings Inc. | Morais Mark A. | COO | S - Sale+OE | $9.98 | -499 | 35,074 | -1% | -$4,980 | |||||
| D | 2025-03-12 | FTRE | Fortrea Holdings Inc. | McConnell Jill G. | CFO | S - Sale+OE | $9.98 | -643 | 36,720 | -2% | -$6,417 | |||||
2025-03-10 | CDNA | Caredx, Inc. | Bickerstaff George | Dir | S - Sale | $18.36 | -20,000 | 103,027 | -16% | -$367,102 | ||||||
2025-03-07 | GRAL | Grail, Inc. | Ragusa Robert P | CEO | S - Sale | $31.21 | -7,625 | 828,662 | -1% | -$237,976 | ||||||
2025-03-07 | GRAL | Grail, Inc. | Ofman Joshua J. | Pres | S - Sale | $31.20 | -2,109 | 559,673 | 0% | -$65,801 | ||||||
2025-03-07 | GRAL | Grail, Inc. | Freidin Aaron | CFO | S - Sale | $31.20 | -1,816 | 335,170 | -1% | -$56,659 | ||||||
2025-03-07 | RDNT | Radnet, Inc. | Swartz David L | Dir | S - Sale | $50.84 | -25,000 | 211,086 | -11% | -$1,271,000 | ||||||
| M | 2025-03-07 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.07 | -29,177 | 370,563 | -7% | -$585,673 | |||||
2025-03-07 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $4.16 | -3,874 | 121,757 | -3% | -$16,116 | ||||||
| D | 2025-03-07 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale+OE | $4.12 | -29,722 | 876,657 | -3% | -$122,455 | |||||
2025-03-07 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $4.12 | -4,818 | 309,702 | -2% | -$19,850 | ||||||
2025-03-07 | VCYT | Veracyte, Inc. | Leite John | Chief Commercial Officer-CLIA | S - Sale | $31.66 | -7,411 | 100,249 | -7% | -$234,630 | ||||||
2025-03-05 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $143.29 | -6,000 | 143,768 | -4% | -$859,734 | ||||||
2025-03-05 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $143.40 | -87,272 | 203,354 | -30% | -$12,515,006 | ||||||
2025-03-06 | SERA | Sera Prognostics, Inc. | Mirza Mansoor Raza | Dir | S - Sale | $4.16 | -99 | 43,885 | 0% | -$412 | ||||||
| D | 2025-03-06 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale+OE | $4.16 | -1,338 | 203,800 | -1% | -$5,566 | |||||
| D | 2025-03-06 | SERA | Sera Prognostics, Inc. | Jackson Benjamin | GC | S - Sale+OE | $4.16 | -2,285 | 138,544 | -2% | -$9,506 | |||||
| D | 2025-03-06 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale+OE | $4.16 | -3,251 | 125,631 | -3% | -$13,524 | |||||
| D | 2025-03-06 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale+OE | $4.16 | -2,044 | 170,850 | -1% | -$8,503 | |||||
| D | 2025-03-06 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale+OE | $4.16 | -540 | 314,520 | 0% | -$2,246 | |||||
2025-03-05 | DGX | Quest Diagnostics Inc | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $174.13 | -5,370 | 72,495 | -7% | -$935,078 | ||||||
| M | 2025-03-05 | RDNT | Radnet, Inc. | Wesdorp Cornelis | Pres, CEO, Digital Health | S - Sale | $51.63 | -5,000 | 55,995 | -8% | -$258,140 | |||||
2025-03-05 | LH | Labcorp Holdings Inc. | Anderson Kerrii B | Dir | S - Sale | $255.64 | -500 | 13,454 | -4% | -$127,817 | ||||||
2025-03-04 | VCYT | Veracyte, Inc. | Febbo Phillip G. | Chief Scientific, Med Officer | S - Sale | $33.35 | -8,037 | 82,540 | -9% | -$268,013 | ||||||
2025-03-04 | VCYT | Veracyte, Inc. | Stapley Marc | CEO | S - Sale | $33.34 | -52,697 | 268,035 | -16% | -$1,756,855 | ||||||
2025-03-04 | VCYT | Veracyte, Inc. | McGuire Annie | SVP, GC | S - Sale | $33.69 | -1,142 | 70,308 | -2% | -$38,476 | ||||||
2025-03-05 | GRAL | Grail, Inc. | Freidin Aaron | CFO | S - Sale | $41.51 | -521 | 336,986 | 0% | -$21,627 | ||||||
2025-03-05 | GRAL | Grail, Inc. | Ofman Joshua J. | Pres | S - Sale | $41.51 | -525 | 561,782 | 0% | -$21,793 | ||||||
2025-03-05 | GRAL | Grail, Inc. | Ragusa Robert P | CEO | S - Sale | $41.51 | -994 | 836,287 | 0% | -$41,261 | ||||||
| D | 2025-03-04 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale+OE | $20.86 | -5,687 | 399,740 | -1% | -$118,619 | |||||
2025-03-05 | FLGT | Fulgent Genetics, Inc. | Kim Paul | CFO, Treasurer | P - Purchase | $15.96 | +100,000 | 348,282 | +40% | +$1,596,470 | ||||||
| D | 2025-03-03 | GH | Guardant Health, Inc. | Joyce Meghan V. | Dir | S - Sale+OE | $42.71 | -100 | 7,714 | -1% | -$4,271 | |||||
2025-03-04 | DGX | Quest Diagnostics Inc | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $175.79 | -716 | 77,865 | -1% | -$125,866 | ||||||
2025-03-04 | DGX | Quest Diagnostics Inc | Prevoznik Michael E | SVP, GC | S - Sale | $175.79 | -592 | 48,400 | -1% | -$104,068 | ||||||
| D | 2025-02-28 | LH | Labcorp Holdings Inc. | Schroeder Mark S | EVP, Pres Diagnostics, COO | S - Sale+OE | $249.23 | -5,339 | 4,960 | -52% | -$1,330,639 | |||||
2025-02-27 | VCYT | Veracyte, Inc. | Leite John | Chief Commercial Officer-CLIA | S - Sale | $33.84 | -5,746 | 71,420 | -7% | -$194,445 | ||||||
2025-02-26 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $160.50 | -5,700 | 347,353 | -2% | -$914,873 | ||||||
2025-02-27 | DGX | Quest Diagnostics Inc | Prevoznik Michael E | SVP, GC | S - Sale | $172.61 | -528 | 44,672 | -1% | -$91,138 | ||||||
2025-02-27 | DGX | Quest Diagnostics Inc | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $172.61 | -824 | 73,606 | -1% | -$142,231 | ||||||
2025-02-25 | LH | Labcorp Holdings Inc. | Van Der Vaart Sandra D | EVP, GC | S - Sale | $251.30 | -1,314 | 2,171 | -38% | -$330,208 | ||||||
2025-02-24 | LH | Labcorp Holdings Inc. | Summy Amy B. | EVP, CMO | S - Sale | $250.40 | -226 | 4,545 | -5% | -$56,590 | ||||||
2025-02-20 | CSTL | Castle Biosciences Inc | Stokes Frank | CFO | S - Sale | $26.70 | -8,046 | 35,319 | -19% | -$214,828 | ||||||
2025-02-20 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale | $48.33 | -116 | 3,078 | -4% | -$5,606 | ||||||
2025-02-20 | DGX | Quest Diagnostics Inc | Prevoznik Michael E | SVP, GC | S - Sale | $170.99 | -604 | 45,486 | -1% | -$103,278 | ||||||
2025-02-19 | DGX | Quest Diagnostics Inc | Plewman Patrick | SVP for Diagnostic Services | S - Sale | $169.71 | -320 | 18,082 | -2% | -$54,307 | ||||||
| M | 2025-02-19 | DGX | Quest Diagnostics Inc | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $170.51 | -1,434 | 74,885 | -2% | -$244,515 | |||||
| D | 2025-02-18 | LH | Labcorp Holdings Inc. | Wilkinson Peter J | SVP, Chief Accounting Officer | S - Sale+OE | $246.10 | -1,413 | 1,993 | -41% | -$347,739 | |||||
2025-02-13 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $4.28 | -3,610 | 103,112 | -3% | -$15,451 | ||||||
2025-02-12 | SERA | Sera Prognostics, Inc. | Mirza Mansoor Raza | Dir | S - Sale | $4.58 | -101 | 43,984 | 0% | -$463 | ||||||
2025-02-12 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $4.58 | -14,075 | 779,459 | -2% | -$64,464 | ||||||
2025-02-12 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale | $4.58 | -5,342 | 158,128 | -3% | -$24,466 | ||||||
2025-02-13 | SERA | Sera Prognostics, Inc. | Jackson Benjamin | GC | S - Sale | $4.58 | -5,915 | 106,239 | -5% | -$27,091 | ||||||
2025-02-12 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $4.58 | -7,297 | 106,722 | -6% | -$33,420 | ||||||
2025-02-12 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale | $4.58 | -5,915 | 125,884 | -4% | -$27,091 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |